Dr. Rabinder Buttar | Chairman, CEO & Founder
Dr Buttar’s clinical experience spans more than three decades within major pharmaceutical companies and within her own organization, Clintec.
Dr Buttar has three decades of experience in the clinical research industry, including positions within Pfizer (Wyeth), GSK (Wellcome) and Astellas (Fujisawa). Dr Buttar graduated with a BSc in Biochemistry from Glasgow University, a PhD in Immunology from Strathclyde, and a certificate in Management from Reading. She served for four years on the board of the Institute of Clinical Research UK (ICR), is an Honorary Fellow of ICR, a Fellow of the Royal Society of Medicine, a Fellow of the Royal Society of Edinburgh, and received an honorary doctorate from the University of the West of Scotland.
In 2014, Dr Buttar was listed by the British Science Council as one of the top 10 practising entrepreneurial scientists in Britain and has previously been named as one of Britain’s top 100 entrepreneurial women (Real Business). During 2015, Dr Buttar was inducted into Strathclyde’s Academy of Distinguished Entrepreneurs, and has received many prestigious awards such as Ernst & Young ‘Scottish Entrepreneur of the Year’, the Institute of Directors ‘Director of the Year’ and Business Woman of the Year (People Make Glasgow); all of her accolades recognize Dr Buttar’s success in global business, entrepreneurship, and leadership.
Clintec itself has also received numerous recognitions, including the Queen’s Award for Enterprise and recent awards such as Scale-Up Business of the Year at the 2016 Minority Supplier Development Awards, the Best Mid-Sized Pharmaceutical Clinical Research Organization at the 2016 International Life Sciences Awards, a finalist in the Export and International Trade category at the Scottish Life Science Awards 2016 and Clinical Research Organization of the Year – UK in 2014.